职位

Editas Medicine

Editas Medicine

Editas Medicine

Genome editing company

Gene Editing

CRISPR Technology

Genomic Medicine

Clinical Research

Rare Diseases

Cambridge, Massachusetts, United States

201-500

2013年成立(第13年)

混合办公

Public

估值

$1.2B

融资总额

$300M

EDIT

$2.91

营收 (2026)

$0

营业利润

$0

Editas Medicine在招职位

1个在招职位

Join Our Team

招聘

Remote

现场办公

全职

查看职位

3个月前

产品与服务

reni-cel

reni-cel

Gene Therapy

ED

EDIT-101

Gene Therapy

ED

EDIT-301

Cell Therapy

CR

CRISPR Gene Editing Platform

Technology Platform

ED

EDIT-201

Gene Therapy

In Vivo Gene Editing Medicines

In Vivo Gene Editing Medicines

Gene Therapy

ED

EDIT-103

Gene Therapy

IN

In Vivo Gene Editing Services

R&D Services

CR

CRISPR/Cas Gene Editing Platform

Platform Technology

EX

Ex Vivo Cell Engineering

R&D Services

EX

Ex Vivo Gene Editing Services

Research Services

EN

Engineered Natural Killer (eNK) Cell Platform

Cell Therapy

ED

EDIT-401

Gene Therapy

领导团队

CS

Charlene Stern

Executive Vice President & General Counsel

KB

Kevin Bitterman

Interim President

DRL

David R. Liu

Founder

FZ

Feng Zhang

Founder

浏览量

0

申请点击

0

Mock Apply

0

收藏

0

评价

4.2

5条评价

工作生活平衡

4.0

薪酬

3.5

企业文化

4.3

职业发展

2.8

管理层

3.5

78%

推荐率

优点

Supportive and collaborative team environment

Great work-life balance and flexible hours

Cutting-edge research opportunities

缺点

Limited career advancement opportunities

High expectations and stress levels

Disorganized management practices

薪资范围

38个数据点

Director

Junior/L3

Director

1份报告

$195,000

年薪总额

基本工资

$150,000

股票

-

$195,000

$195,000

面试评价

39条评价

难度

3.4

/ 5

时长

2-5w

录用率

35%

体验

正面 67%

中性 15%

负面 18%

面试流程

1

Phone Screen

2

Technical Interview

3

Hiring Manager

4

Team Fit

联系方式与地址